New Questions About Generic Drugs
http://thedianerehmshow.org/shows/1990-01-01/new-questions-about-generic-drugs
An Indian scientist works inside a laboratory of the Research and Development Centre of Natco Pharma Ltd. in Hyderabad, India, Tuesday, March 13, 2012. India effectively ended Bayer's monopoly on a patented cancer drug Monday, licensing a much cheaper generic under a unique law aimed at keeping costs affordable. In a decision likely to upset Western pharmaceuticals, the patent office approved Natco Pharma Ltd.'s application to produce the kidney and liver cancer treatment sorefinib.
(AP Photo/Mahesh Kumar A.)
Generic drugs account for 80 percent of the pharmaceuticals prescribed to Americans. Why they’re cheaper and who’s responsible when something goes wrong.
Guests
Ralph Neas
president and ceo, Generic Pharmaceutical Association
Katie Thomas
reporter, New York Times
Dr. Sidney Wolfe
director of the Health Research Group at Public Citizen; editor of WorstPills.org
Steven Brill
journalist and author of "Bitter Pill: How outrageous pricing and egregious profits are destroying our health care," a special report for Time Magazine's March 4, 2013, edition.
Please familiarize yourself with our Code of Conduct and Terms of Use before posting your comments.
